World Health Organization Accredited National Reference Laboratory for Measles and Rubella, National Institute of Virology [Indian Council of Medical Research], Pune, Maharashtra, India.
J Med Virol. 2017 May;89(5):753-758. doi: 10.1002/jmv.24702. Epub 2016 Oct 14.
The Government of India is accepted to participate in the measles elimination and rubella control goal 2020, hence genetic characterization of measles viruses (MeV) becomes essential. At National Reference Laboratory (National Institute of Virology, Pune), the throat swabs/urine specimens (n = 380) or PCR products (n = 219) obtained from the suspected measles cases were referred for the molecular testing and subsequently, MeV nucleoprotein (N) gene sequencing/genotyping. In addition, 2,449 suspected measles cases, mainly from the Maharashtra state were referred for the laboratory diagnosis. A detailed study was performed on N gene sequences obtained during last two decades. Indian MeV sequences obtained during 2011-2015 were compared with 1996-2010 sequences and genetic divergence was studied. Circulation of measles genotypes B3 (n = 3), D4 (n = 49), and D8 (n = 351) strains were observed in 19 States and three Union Territories of India. In addition, 64 measles viruses were isolated from 253 throat swab or urine specimens obtained from the suspected measles cases. During 2011-2015, 67.9% (1,663/2,449) suspected measles cases were laboratory confirmed. Molecular studies showed circulation of measles genotype B3 in India along with prominently circulating genotypes D4 and D8 except D7 strains. The genetic diversion within Indian B3, D4, and D8 genotypes was 0.3%, 1.1%, and 2.1%, respectively. The genetic divergence of Indian B3, D4, and D8 measles strains with the WHO reference sequences was 2.5%, 2.6%, and 1.8%, respectively. It is crucial data for national immunization program. More measles/rubella genotyping studies are necessary to track transmission and to support measles elimination and rubella control. J. Med. Virol. 89:753-758, 2017. © 2016 Wiley Periodicals, Inc.
印度政府已承诺参与 2020 年麻疹消除和风疹控制目标,因此麻疹病毒(MeV)的基因特征分析至关重要。在国家参考实验室(浦那国家病毒学研究所),从疑似麻疹病例中采集的咽拭子/尿液标本(n=380)或 PCR 产物(n=219)被送检进行分子检测,随后对 MeV 核蛋白(N)基因进行测序/基因分型。此外,还将 2449 例疑似麻疹病例,主要来自马哈拉施特拉邦,送检进行实验室诊断。对过去 20 年获得的 N 基因序列进行了详细研究。将 2011-2015 年期间获得的印度 MeV 序列与 1996-2010 年的序列进行比较,并研究遗传分化。在印度的 19 个邦和 3 个联邦属地中,观察到麻疹基因型 B3(n=3)、D4(n=49)和 D8(n=351)的流行。此外,从 253 例疑似麻疹病例的咽拭子或尿液标本中分离出 64 株麻疹病毒。2011-2015 年,67.9%(1663/2449)的疑似麻疹病例得到实验室确认。分子研究表明,除 D7 株外,印度还存在麻疹基因型 B3,以及主要流行的基因型 D4 和 D8。印度 B3、D4 和 D8 基因型的遗传分化分别为 0.3%、1.1%和 2.1%。印度 B3、D4 和 D8 麻疹株与世界卫生组织参考序列的遗传差异分别为 2.5%、2.6%和 1.8%。这是国家免疫规划的关键数据。需要进行更多的麻疹/风疹基因分型研究,以跟踪传播情况,支持麻疹消除和风疹控制。J. Med. Virol. 89:753-758, 2017. © 2016 Wiley Periodicals, Inc.